Zealand Pharma A/S
ZLDPF
$61.00
$3.506.09%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.39B | 8.01M | 9.07M | 11.13M | 53.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.39B | 8.01M | 9.07M | 11.13M | 53.63M |
| Cost of Revenue | -797.70K | 509.10K | 1.12M | 2.76M | 4.49M |
| Gross Profit | 1.39B | 7.50M | 7.95M | 8.37M | 49.14M |
| SG&A Expenses | 67.14M | 62.00M | 58.47M | 45.66M | 39.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 29.65M | 3.06M | 14.00K | 470.00K | -214.10K |
| Total Operating Expenses | 282.67M | 212.15M | 193.04M | 173.50M | 157.90M |
| Operating Income | 1.10B | -204.14M | -183.98M | -162.37M | -104.27M |
| Income Before Tax | 1.11B | -171.06M | -157.05M | -153.68M | -103.59M |
| Income Tax Expenses | 81.26M | -668.60K | -671.40K | -671.70K | -661.40K |
| Earnings from Continuing Operations | 1.02K | -170.39 | -156.38 | -153.01 | -102.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.02B | -170.39M | -156.38M | -153.01M | -102.93M |
| EBIT | 1.10B | -204.14M | -183.98M | -162.37M | -104.27M |
| EBITDA | 1.11B | -201.04M | -180.75M | -159.28M | -101.48M |
| EPS Basic | 14.47 | -2.49 | -2.36 | -2.42 | -1.68 |
| Normalized Basic EPS | 9.69 | -1.64 | -1.55 | -1.56 | -1.07 |
| EPS Diluted | 14.25 | -2.49 | -2.36 | -2.42 | -1.69 |
| Normalized Diluted EPS | 9.55 | -1.64 | -1.55 | -1.56 | -1.07 |
| Average Basic Shares Outstanding | 282.73M | 274.69M | 265.72M | 253.35M | 241.07M |
| Average Diluted Shares Outstanding | 283.71M | 274.69M | 265.72M | 253.35M | 242.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |